ICCS Infection Prevention & Control Newsletter: December 2021

This issue covers some of the most significant news from December. Topics include Omicron, accreditation standards, face-mask practices, updated CDC guidelines, and antibiotic resistance.

Note: Stay tuned for the annual special edition of the ICCS Infection Prevention & Control Newsletter where we highlight some of the biggest news and ICCS reports from 2021.

* * *

CDC Confirms First U.S. Case of Omicron COVID Variant Has Been Detected in California — The month kicked off with this news. Within just a few weeks, Omicron became the dominant COVID strain.

Holiday Gathering: Omicron Precautions From ICCS — ICCS Founder Phenelle Segal, RN, CIC, FAPIC, provided advice on how to travel and gather more safely as the country confronted the Omicron surge — guidance that is worth following even with the holidays behind us.

Hospitals Confront New Accreditation Standards to ComeMedPage Today discusses possible new hospital Joint Commission standards for 2022 in areas that include medication management, antimicrobial stewardship, community-acquired pneumonia, and other infections.

2020 Report to Congress: CMS Remains Critical of AO Performance — Infection control, missed deficiencies within the physical environment, and a few other issues were highly cited in CMS' latest annual report card on the performance of accrediting organizations.

High-Flow Oxygen Reduces Need for Mechanical Ventilation in Severe COVID-19 — Investigators found that patients with severe COVID who received high-flow oxygen therapy were less likely to need mechanical ventilation and had a shorter time to clinical recovery.

New Study Identifies Most Effective Face-Mask Practices to Reduce Spread of Infection — Study findings provide guidance for increasing the effectiveness of face masks.

Update to 'Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients' — CDC updated four parts of the "Epidemiology and Control of Selected Infections" section of the "Guideline for Infection Control in Healthcare Personnel." The updates concern diphtheria, group A streptococcus, meningococcal disease, and pertussis.

Candida auris: Coming Soon to a Facility Near You? — This is a good summary about and guidance concerning Candida auris, which we are increasingly seeing throughout the country.

Hope on the Horizon: Treatment for Carbapenem-Resistant Acinetobacter baumannii Infections — Study results provide hope for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) infections.

Brown Introduces Legislation to Combat Threat of Antibiotic Resistant 'Superbugs' — U.S. Sen. Sherrod Brown reintroduced The Strategies to Address Antibiotic Resistance (STAAR Act), which would provide a multipronged strategy to limit the growing impact of antibiotic resistance.

CDC Launches Networks to Boost Global Response to Antibiotic Resistance — The CDC announced an initiative to bolster the global response to antimicrobial resistance, awarding millions of dollars to organizations in more than 50 countries.

Add Biopreparedness to IP Checklist — A column in Infection Control Today details why infection preventionists should "harness the current attention to biopreparedness and use the momentum to build the foundations for strong local programs that can be sustained through future waves of competing priorities."

'Implementation Science' Critical to Reducing Antibiotic Resistance — A white paper published in Infection Control & Hospital Epidemiology outlined the steps involved in designing and conducting an implementation research study in support of antibiotic stewardship.

Holiday Gathering: Omicron Precautions From ICCS

By Phenelle Segal, RN, CIC, FAPIC, Founder, Infection Control Consulting Services (ICCS)

The risk of getting infected with COVID-19 when gathering with friends/family during the holidays is lower if the people congregating are all vaccinated and boosted. If not boosted, people should seriously consider the added protection it provides. Limiting the size of crowds gathering is also advisable.

Fortunately, the symptoms of Omicron to date in vaccinated persons appear to be mild and short-lived, but we don't want to pass it to others, nor do we want to be presumptive. Omicron is tricky

The following steps should be highly considered:

1. Symptoms: Omicron is causing cold- or allergy-like symptoms in vaccinated persons. There is more severe disease in the unvaccinated, so limit or forego contact with them if possible. Scratchy or sore throat seems to be high on the list of initial symptoms. I highly suggest that if anyone has any symptoms suggested of "allergies" or a cold/respiratory infection, they isolate for at least 5-7 days (as per Dr. Fauci during media discussion) and symptoms must be significantly better (no fever for 24 hours or more without fever reducing meds). Testing is an option too (strategies discussed below). Omicron is highly transmissible while acting like a mild infection.

2. It is also causing headache, body aches and mild GI symptoms with some people complaining of a mild fever — all indicative of general viral syndromes particularly in the winter.

3. There are other lousy viruses circulating, and I suggest these strategies so that you're protected from these additional illnesses.

4. Testing: If a person tests negative via rapid test (particularly if symptomatic), it doesn't mean they are COVID free. The question is whether the "negative" person is incubating it and are they transmissible? That's based on how much virus is in the nasal passages or throat. Could they have another respiratory virus?

In summary, if anyone has any cold-like symptoms or thinks they have allergies, they must isolate as they can infect a lot of people if it's "hidden" COVID or another virus. Symptoms and a negative rapid test (ensure you research which home-based test kits are reliable) could still be a mild Omicron infection that is transmissible, but we don't know how infectious.

5. Rapid test kits are effective at detecting Omicron, but it all depends on whether there is enough virus to detect and at what stage the illness is tested. There is a risk of people who are infected testing negative, but if they are asymptomatic, it is thought that the likelihood of transmitting Omicron may be less. However, we really don't know all the details at this juncture.

6. Before traveling and during a trip, you could undertake screening daily to help identify the virus. There is no hard science to support this strategy, and you will need access to tests to do so, but some took this approach during the Thanksgiving holiday and will also be doing so for the upcoming holidays.

7. It is advisable to stay home or isolate if you develop symptoms while away.

8. Isolation: If a test is positive on rapid and/or PCR, CDC has not changed its isolation guidelines to date (I’m expecting updates soon). but, as mentioned above, Dr. Fauci has stated 5-7 days may be all that is needed, provided the person is no longer symptomatic and feeling better. Bear in mind though that these are suggestions and not evidence-based, written guidelines. 

Strategies to Prevent Infection: The Most Important Information

Follow these strategies to reduce your risk of infection:

  • Step up your masks to a well-fitting KN95 that has at least 5 layers or an N95 that is vetted by OSHA/NIOSH.

  • Masks should be worn in every indoor setting prior to gathering, including elevators, offices (even if others are masked and/or the office is quiet), stores, and public transportation.

  • If possible, limit mass transit use or avoid altogether as COVID and respiratory viruses, including the flu and RSV, are also circulating. Given how many people take mass transit, the amount of circulating virus is exponentially increased, and we suspect that virus can bypass your mask if it is not well fitted.

  • Always keep your fingers away from your eyes and nose.

  • Wash your hands when you get home from shopping or other tasks outside the house. Do so when inside the house at intervals, but especially upon returning home.

  • I'd hold off on going to the gym during this heightened period, but if you must go, I'd wear at a minimum a tight fitting KN95.

Finally, enjoy your time together and be wise!

ICCS Infection Prevention & Control Newsletter: November 2021

This issue covers some of the most significant news from November. Topics include nursing home federal guidance, omicron, booster shots, antimicrobial infections, COVID test kit recall, and breakthrough infections.

* * *

CMS Increases Oversight of Nursing Home Survey Process and Expands Nursing Home Visitation Policy in 2 New Guidances — CMS issued two memos affecting nursing homes. They concern 1) increased oversight and surveyor scrutiny, and 2) resident visitation. An important note: CMS has instructed surveyors to pay particularly close attention to facilities with higher infection rates but lower COVID vaccination rates.

Experts Urge Vaccinations to Protect Against Omicron Variant, Other Possible Mutations — ICCS Founder Phenelle Segal, RN, CIC, FAPIC, discussed the omicron variant with WPBF 25 News.

The FDA Authorizes COVID Booster Shots for All U.S. Adults — FDA gave the green light for fully vaccinated Americans age 18 and older to receive a COVID booster.

FDA Panel Recommends Molnupiravir, First Pill for COVID-19 — The FDA's antimicrobial drugs advisory committee voted to recommend the use of Merck's molnupiravir — the first pill indicated to treat COVID-19 infections and prevent hospitalization and death. If taken within the first 5 days of infection, the pills offers a 30% reduction in the risk of hospitalization and death.

New Guidance for Treating Antimicrobial-Resistant Infections Released — IDSA issued new guidance for treating three of the most common drug-resistant pathogens: AmpC b-lactamase producing Enterobacterales (AmpC-E), Carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia.

FDA Recalling 2 Million Ellume At-Home COVID-19 Test Kits Because of False Positives — FDA announced a recall of COVID-19 test kits made by biotech company Ellume.

Avoiding False Positives for SARS-CoV-2 When Using Rapid Antigen Tests — We put misinformation at the top of our 2021 "10 of the Scariest Healthcare Infections and Threats," and for good reason. This story details an unnecessary study that became necessary due to misinformation.

What Data From 20 Systems Shows About Breakthrough Infections — This report provides interesting statistics concerning trends in breakthrough infections and hospitalizations.

How Did We Develop a COVID-19 Vaccine So Quickly? — This article provides a good answer to a question many have asked over the past year.

ICCS Infection Prevention & Control Newsletter: October 2021

This issue covers some of the most significant news from October. Topics include PPE, drug-resistant infections, MRSA, vaccine hesitancy, RSV, influenza, and malaria.

* * *

Personal Protective Equipment: An Ongoing Challenge — In this blog post, ICCS Founder Phenelle Segal, RN, CIC, FAPIC, discussed PPE fatigue and the importance of employers keeping current with and following guidelines and best practices.

International Infection Prevention Week — Phenelle contributed a column about IIPW to the Texas Ambulatory Surgery Center Society. IIPW took place Oct. 17-23.

Drug-Resistant Infections Led to $1.9 Billion in Health Care Costs, More Than 10,000 Deaths Among Older Adults in One Year — The results of a new study reminded us of the significant burden of antibiotic-resistant infections on patients and the healthcare system

The Long Arm of MRSA — In a 6-month observational study, researchers found environmental shedding of MRSA during 45% of appointments outside hospital rooms or during outpatient clinic visits. Not good, to say the least.

Studies Provide Insights Into COVID Vaccine Hesitancy — A particularly valuable read for those involved in vaccine education and development of public health communication strategies.

2021 National Survey: Attitudes about Influenza, Pneumococcal Disease, and COVID-19 — A National Foundation for Infectious Diseases survey also provided valuable insight into perspectives on vaccines.

RSV Is Common, Dangerous Infection: What Parents Need to Know — Respiratory syncytial virus circulated widely and hit regions hard this past summer, which is unusual as it's typically seen in the late fall and winter. This year, adults have also been especially hard hit by this highly contagious infection. Learn about RSV and its precautions.

The Differences and Similarities Between the Flu and COVID-19 — Flu season is here. This piece from American Heart Association News does a good job comparing the flu to COVID.

WHO Recommends Groundbreaking Malaria Vaccine for Children at Risk — Some great global news from early in the month.

3D-Printed Vaccine Patch Offers Vaccination Without a Shot — Now this is pretty neat!

ICYMI: 10 of the Scariest Healthcare Infections and Threats (2021 Edition) — ICCS published its third annual special report to coincide with Halloween.

10 of the Scariest Healthcare Infections and Threats (2021 Edition)

We're back at it again. For the third consecutive year, the Infection Control Consulting Services (ICCS) team — with a little help from followers of our LinkedIn page — has come up with its list of 10 of the scariest healthcare infections and threats in conjunction with Halloween. Little did we know that when we assembled our last list, we'd still be dealing with the top threat a year later (we think you can guess what it was).

Without further ado, here's this year's list!

1. Misinformation

We had this at #5 on the 2020 list. While the order of these Halloween-themed lists is not meant to represent any significance, we are intentionally placing misinformation at the top of this year's list. The spread of misinformation and disinformation — with the latter indicating deliberate, malicious intent — concerning COVID-19 is indirectly and directly causing harm and the loss of lives. If we hope to end this pandemic sooner than later, we must greatly reduce the spread and impact of misinformation.

2. Delta variant

In January, it looked like the country was heading in a good direction with COVID-19. By the end of June, the 7-day moving average of reported cases was around 12,000. About one month later, that figure surpassed 60,000 — despite the availability of vaccines. The primary contributing factor: the Delta variant, the predominant and more virulent variant of the SARS-CoV-2 virus.

There's a mix of good and possible bad news regarding the Delta variant today: The good news is that after the 7-day average surpassed more than 175,000 cases in mid-September, we've been on a steady decline since, down to about 72,000 on October 27. This has been helped by increases in vaccinations. The possible bad news: Delta is not going to be the final variant we confront. Hopefully future variants are not worse than Delta and we continue to get more people vaccinated and now receiving their booster shots.

3. Healthcare-acquired infections

A CDC analysis published in September that compared infection rates before and during pandemic revealed a significant increase in healthcare-associated infections (HAI) in 2020. The news, while not surprising, was still a gut punch considering how much work has gone into bringing down HAIs in recent years.

ICCS Founder Phenelle Segal, RN, CIC, FAPIC, responded to the report, stating, "Concerns about COVID-19 negatively impacting HAI prevention strategies and decades of progress is now a reality. We must be reminded that it is incumbent on us as infection preventionists to stress the critical need for infection prevention practices to return to pre-pandemic times, despite the ongoing serious challenges COVID-19 has created. Ongoing education, monitoring, and feedback is critical to patient safety."

4. Drug-resistant infections

Every chance we get, we try to bring attention to news and developments concerning antibiotic-resistant infections. They remain a significant challenge and threat. Leading up to the pandemic, we were seeing more resources dedicated to reducing the burden of antimicrobial resistance. Unfortunately, the pandemic shifted much of these away. The sooner we can get back to giving drug-resistant infections the attention they deserve, the better. After all, a recent study of 2017 data provided some eye-opening statistics. Infections caused by bacteria resistant to multiple antibiotics led to:

  • $1.9 billion in healthcare costs

  • Nearly 450,000 days in the hospital

  • Nearly 12,000 deaths among older adults across the United States

5. MRSA

We thought it would be worthwhile to call out methicillin-resistant Staphylococcus aureus (MRSA) as a multidrug-resistant organism that has seen a significant spike over the past few years. Preliminary data for the last quarter of 2020 revealed a jump of 34% in MRSA compared with the same quarter in 2019, according to a recent study. In some states like Arizona and New Jersey, rate increases approached 100%. This is obviously not the data we want to see but knowing that this has become an area where rates are rising should encourage us to refocus our efforts on getting the figures back down.

6. Fungal infections and emerging anti-fungal resistance

Much of the attention around infections and antibiotic-resistance is paid to microbes like bacteria, such as Acinetobacter, C. difficile, and S. aureus (MRSA). But the rise of fungus infections and antifungal resistance is a problem requiring much more attention.

In the CDC's Antibiotic Resistance Threats in the United States, 2019, the agency included Candida auris as an urgent threat and dozens of Candida species as a serious threat. The CDC also put Aspergillus on its watch list. Outbreaks of C. auris have been reported in COVID-19 units of acute care hospitals. 

7. Poorly managed space

This is one of the suggestions that came from a LinkedIn follower, and we couldn't agree more with it. While COVID-19 has made healthcare providers more cognizant of the spaces they work in, and we've seen some changes and improvements that have helped reduce patient and staff infection risk (such as those concerning ventilation and the usage of separate entrances for potentially contagious patients), there's still considerable work to be done to further decrease threats from the built environment.

Just a few of the areas we believe deserve more attention and consideration: placement of handwashing stations, patient and staff flow, sink-to-bed ratios, HVAC, appropriate equipment for the space, and allocation of space for the delivery of virtual services. As one final example, in our first "10 of the Scariest Healthcare Infections and Threats," we called attention to the infection risks associated with the placement of hospital sinks next to toilets.

8. Supply chain challenges

Coverage of supply chain issues are all over the news these days, with many reports focusing on how these issues may disrupt holiday shopping. That's the least of our worries. Supply chain issues are expected to persist well into 2022, affecting everything from personal protective equipment to drug shortages to semiconductor chips that power equipment and devices. When supply chain issues force healthcare organizations to deviate from their policies, procedures, and preferred care processes, we know the risk of infection increases.

9. Healthcare worker burnout

  • "Half of health workers report burnout amid COVID-19" (American Medical Association)

  • "Health workers know what good care is. Pandemic burnout is getting in the way" (NPR)

  • "Medical burnout: Breaking bad" (AAMC)

  • "Frontline Healthcare Workers Aren't Feeling the 'Summer of Joy'" (New York Times)

  • "Burned out by the pandemic, 3 in 10 healthcare workers consider leaving the profession" (The Washington Post)

The list of reports about healthcare worker burnout can go on and on. Burnout is a major problem facing our industry. We know that burnout causes impaired quality of care and even medical errors, both of which can contribute to increases in infections and infection risk. If you're feeling burned out, don't ignore it. Take action! Mayo Clinic offers some good guidance around this serious matter here.

10. Complacency

When we were discussing this list, we knew we wanted to end with something impactful. We kept coming back to the advice we gave in last year's list about COVID-19. "Be vigilant," we said. We hope that describes you over the past year.

And now we hope that will continue to describe you in the year ahead of us. There's no time for complacency, even with the positives we're seeing around declining new cases and test positivity rates, and now the authorizations of vaccinations for children. If we become complacent, we can very easily undo the progress we've made. But by successfully fighting any desire to become complacent, we can continue building on our accomplishments. Hopefully when we put together this list next year, we'll be able to speak about COVID-19 in the past tense.

What did we omit? What are your scariest healthcare infections and threats?

Thank you for reading our list! By no means is it comprehensive, but, as we've tried to do with this list every year, we've worked to identify a variety of threats that we feel are deserving of a little more attention and that we hope will help you think about the top threats facing the healthcare industry, your organization, and your role as a healthcare professional. If we omitted a scary infection or threat that would be on your list, let us know on LinkedIn!